High-yield points
- LDD = dysplastic cerebellar gangliocytoma with a "tiger-striped" T2 pattern.
- Adult-onset LDD means germline PTEN until proven otherwise (83% of lesions PTEN-mutant). LDD is a defining feature of Cowden syndrome .
- Pediatric LDD may lack PTEN mutations, but test anyway .
- Symptomatic LDD: decompress and resect. There is no clean plane, and it can recur .
- A PTEN diagnosis brings high cancer risks: breast 85%, thyroid 35%, endometrium 28%, kidney 34%. Survey the patient and the family .
- In children: macrocephaly plus autism or developmental delay. Think PHTS (autism ; macrocephaly, see caveats).
PTEN hamartoma tumor syndrome (PHTS) is the spectrum of disorders caused by germline PTEN mutations . It includes:
- Cowden syndrome, the principal one;
- Bannayan–Riley–Ruvalcaba syndrome, the pediatric-onset presentation (see caveats).
PTEN normally restrains PI3K–AKT–mTOR signaling, so its loss causes hamartomas and cancer.
For the neurosurgeon:
- The hallmark lesion is Lhermitte–Duclos disease (LDD), a dysplastic gangliocytoma of the cerebellum .
- The usual clinical clue in a child is macrocephaly, often with autism or developmental delay (see caveats).
PTEN hamartoma tumor syndrome
- Inheritance: autosomal dominant.
- Diagnosis: the original consortium criteria for Cowden syndrome proved much less specific than first thought. They were revised in 2013 into evidence-based criteria covering the whole PTEN spectrum .
- Features added:
- neurodevelopmental: autism spectrum disorder;
- cancers: renal cell and colon cancer;
- skin and genital: penile macules (freckling), testicular lipomatosis;
- gut: glycogenic acanthosis of the esophagus;
- vascular anomalies.
- Features not supported as criteria: benign breast disease, uterine fibroids and genitourinary malformations.
- Cancer risk (368 PTEN mutation carriers identified among 3,399 prospectively recruited people) . Estimated lifetime risks:
- breast 85.2%;
- thyroid 35.2%;
- endometrium 28.2%;
- kidney 33.6%;
- colorectum 9.0%;
- melanoma 6%.
- This is why a PTEN diagnosis made in a child leads to lifelong, family-wide cancer surveillance.
- In children: suspect PHTS in a child with macrocephaly plus autism or developmental delay, vascular anomalies, lipomas or penile freckling. Refer for genetics (see caveats).
Lhermitte–Duclos disease
- What it is: a hamartomatous overgrowth of the cerebellum, also called dysplastic gangliocytoma .
- Enlarged cerebellar folia have a thickened, abnormal granular layer, which produces the striated, "tiger-striped" T2 pattern on MRI .
- Link to PTEN:
- 83% (15 of 18) of LDD lesions carried a PTEN mutation .
- Every adult-onset patient tested had a germline PTEN mutation, whether or not they had overt Cowden features.
- LDD is a defining feature of Cowden syndrome. Anyone with LDD should be counseled as having Cowden syndrome .
- In children it may be different:
- the three LDD cases without PTEN mutations were diagnosed at ages 1, 3 and 11 ;
- pediatric LDD may therefore arise by another mechanism, but genetic testing is still warranted.
- Presentation:
- headache;
- cerebellar signs;
- cranial nerve palsies;
- obstructive hydrocephalus from compression of the fourth ventricle.
- Many lesions are found incidentally (see caveats).
- Imaging: a unilateral cerebellar mass with the striated, "tiger fur" T2 pattern . It often has little or no enhancement (see caveats).
Management of LDD
- Asymptomatic: observe with serial MRI.
- Symptomatic (mass effect, hydrocephalus):
- posterior fossa decompression and resection relieve mass effect and provide tissue ;
- surgery is recommended at the onset of neurological symptoms .
- Surgical challenges (see caveats):
- the lesion has no clear plane with normal cerebellum, so aim to decompress, not to resect aggressively;
- the dysplastic tissue is vascular;
- recurrence can occur after subtotal resection.
- Hydrocephalus: may need CSF diversion if decompression does not relieve it.
- Any patient with LDD:
- germline PTEN testing;
- referral for PHTS cancer surveillance .
Other neurological features of PHTS
- Macrocephaly: a consistent pediatric sign (see caveats).
- Autism: recognized as a PHTS phenotype, and the cerebellum may be involved in its pathogenesis .
- Vascular anomalies: including intracranial developmental venous anomalies .
- Medulloblastoma: rare germline PTEN variants have been identified in medulloblastoma .
Related topics
- Benign vs Malignant Macrocephaly: evaluating the macrocephalic child.
- Medulloblastoma: Molecular Classification and Prognosis: germline PTEN variants occur in rare cases.
- MCAP: another PI3K–AKT–mTOR overgrowth syndrome with macrocephaly.
- Li-Fraumeni Syndrome: another cancer-predisposition syndrome needing family-wide surveillance.
References
- Pilarski R, Burt R, Kohlman W, et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst 2013;105(21):1607–1616. doi:10.1093/jnci/djt277. PMID 24136893. verified
- Zhou XP, Marsh DJ, Morrison CD, et al. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet 2003;73(5):1191–1198. doi:10.1086/379382. PMID 14566704. verified
- Gambini D, Ferrero S, Bulfamante G, et al. Cerebellar phenotypes in germline PTEN mutation carriers. Neuropathol Appl Neurobiol 2024;50(2):e12970. doi:10.1111/nan.12970. PMID 38504418. verified
- Tan MH, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012;18(2):400–407. doi:10.1158/1078-0432.CCR-11-2283. PMID 22252256. verified
- Lakicevic G, Tinjak-Demic S, Lakicevic S, et al. Two illustrative cases of adult Lhermitte-Duclos disease and a systematic review of literature related to surgical management. Brain Spine 2025;5:104258. doi:10.1016/j.bas.2025.104258. PMID 40469941. verified
Verification (2026-11-17):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- Bannayan–Riley–Ruvalcaba syndrome;
- autosomal dominant inheritance;
- the pediatric referral triggers;
- LDD histology and symptoms;
- observation of asymptomatic LDD;
- the surgical challenges (no plane, vascularity, recurrence);
- developmental venous anomalies as the vascular anomaly;
- macrocephaly as the leading pediatric sign;
- MRI being usually diagnostic, and the enhancement pattern.
- Reference 5's systematic review abstract gives no pooled outcome numbers.
- References 2, 4 and 5 are largely adult data.
- The figure is an original schematic.